聯邦醫療保險D部分
參考文獻

↑  Kirchhoff, Suzanne M.  (PDF). Washington, DC: Congressional Research Service. August 13, 2018  [29 August 2018]. （原始内容 (PDF)存档于2021-05-04）.
↑  . www.cms.hhs.gov. 9 February 2018  [2020-10-09]. （原始内容存档于2010-03-20）.
1 2 3 4 5  "Medicare: A Primer," 的存檔，存档日期2010-06-12. Kaiser Family Foundation, April 2010.
1 2  Jack Hoadley, Juliette Cubanski, Elizabeth Hargrave, Laura Summer, and Tricia Neuman, "Medicare Part D Spotlight: Part D Plan Availability in 2010 and Key Changes Since 2006," （页面存档备份，存于） Kaiser Family Foundation, November 2009
↑  August 24, Rhys Dipshan |; AM, 2020 at 10:01. . BenefitsPRO.   [2020-09-18]. （原始内容存档于2020-10-08） （英语）.
↑  . MedicareFAQ. 2020-02-12  [2020-09-18]. （原始内容存档于2021-01-08） （美国英语）.
↑  "Medicare Support Center: Late Enrollment Penalty (LEP)," Oct. 15, 2009
↑  "Refill Report: Understanding & Avoiding Late Enrollment Penalty" 的存檔，存档日期2016-10-12. Dec. 21, 2015
↑  Miller, Daniel P.; Yeo, Jungwon. . American Journal of Health Economics. 2018-03-05, 5 (2): 191–226. ISSN 2332-3493. S2CID 9473459. doi:10.1162/ajhe_a_00119.
↑  . www.medicare.gov.   [2018-03-29]. （原始内容存档于2019-09-25） （英语）.
↑  .   [2020-10-09]. （原始内容存档于2021-02-26）.
↑  .   [2020-10-09]. （原始内容存档于2021-02-27）.
↑  Healthcare Reform: The Doughnut Hole and Me (Part II) （页面存档备份，存于）, MyHealthCafe.com.
↑  Elizabeth Hargrave; Jack Hoadley; Katie Merrelli; Juliette Cubansk,  (PDF), The Kaiser Family Foundation, December 2007  [17 October 2015], （原始内容 (PDF)存档于2012-09-13）
↑  Jack Hoadley, Jennifer Thompson, Elizabeth Hargrave, Katie Merrell, Juliette Cubanski and Tricia Neuman "MEDICARE PART D 2008 DATA SPOTLIGHT: The Coverage Gap," （页面存档备份，存于） Kaiser Family Foundation, November 2007
↑  Jack Hoadley; Elizabeth Hargrave; Katie Merrelli; Juliette Cubansk; Tricia Neumani,  (PDF), The Kaiser Family Foundation, November 2007  [17 October 2015], （原始内容 (PDF)存档于2013-04-23）
↑   (PDF). CMS. 2 April 2012  [16 March 2021]. （原始内容 (PDF)存档于2020-10-26）.
↑  .   [2020-10-09]. （原始内容存档于2021-03-14）.
↑   (PDF). （原始内容 (PDF)存档于February 3, 2007）.
↑   (PDF).   [2007-02-01]. （原始内容 (PDF)存档于2011-07-17）.
↑  Medicare Part D / Prescription Drug Benefits: PART D COVERED DRUGS （页面存档备份，存于）, medicareadvocacy.org
↑  Elias, Eve Carolyn.  (PDF). The University of Tennessee (学位论文). Master of Science. May 2011: 54  [17 October 2015]. （原始内容 (PDF)存档于31 January 2016）.
↑  https://web.archive.org/web/20101007210145/http://www.medicare.gov/Contacts/staticpages/ships.aspx
↑  https://web.archive.org/web/20050317093810/http://money.cnn.com/best/magazine_archive/2003/09/HEA-01.html
↑  "MEDICARE DRUG PLANS STRONG AND GROWING," （页面存档备份，存于） Centers for Medicare and Medicaid Services (CMS) Press Release, Tuesday, January 30, 2007
↑  Teresa A. Keenan, "Prescription Drugs and Medicare Part D: A Report on Access, Satisfaction, and Cost," （页面存档备份，存于） AARP, November 2007 (News Release: AARP Survey Finds Medicare Drug Plans are Prescription for Healthy Drug Behaviors)
↑  2009 ANNUAL REPORT OF THE BOARDS OF TRUSTEES OF THE FEDERAL HOSPITAL INSURANCE AND FEDERAL SUPPLEMENTARY MEDICAL INSURANCE TRUST FUNDS （页面存档备份，存于）, Table II.B1.—Medicare Data for Calendar Year 2008, Page 5 (Page 11 in pdf)
↑  Decarolis, Francesco; Polyakova, Maria; Ryan, Stephen P. . NBER. 2015-06-01  [2020-10-09]. （原始内容存档于2021-03-11）.
↑  The Institute of Medicine. . The National Academies Press. 2006  [2006-07-21]. [永久]
1 2  Amanda Gardner, "Medicare Prescription Drug Benefit Shows Mixed Results," （页面存档备份，存于） The Washington Post, April 22, 2008
↑  Jeanne M. Madden et al., "Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D," （页面存档备份，存于） Journal of the American Medical Association, 2008;299(16):1922–1928
↑  Zhang, JX; Yin, W; Sun, SX; Alexander, GC. . J Gen Intern Med. 2008, 23 (10): 1673–8. PMC 2533371 . PMID 18661190. doi:10.1007/s11606-008-0742-6.
↑  Zhang, J; Yin, W; Sun, S; Alexander, GC. . Journal of General Internal Medicine. 2008, 23: 1673–1678. PMC 2533371 . PMID 18661190. doi:10.1007/s11606-008-0742-6.
↑  Liu, FX; Alexander GC; Crawford SY; Pickard AS; Hedeker D; Walton SM. . Health Services Research. August 2011, 46 (4): 1104–1123. PMC 3165180 . PMID 21609328. doi:10.1111/j.1475-6773.2011.01273.x.
↑  Basu, A; Yin W; Alexander GC. . Health Services Research. 1. February 2010, 45 (1): 133–151. PMC 2813441 . PMID 20002765. doi:10.1111/j.1475-6773.2009.01065.x.
↑  Wettstein, Gal. . American Economic Journal: Economic Policy. 2020, 12 (1): 389–417. ISSN 1945-7731. doi:10.1257/pol.20160560 （英语）.
↑  . www.aeaweb.org.   [2020-03-16]. （原始内容存档于2020-12-25）.
↑  Austin, Frakt; Steven D. Pizer; Roger Feldman. . Health Economics. May 2012, 21 (5): 485–95. PMID 21506191. S2CID 41721060. doi:10.1002/hec.1733.
↑   (PDF). Families USA. 2007  [2012-05-10]. （原始内容 (PDF)存档于2014-12-26）.
↑  Stiglitz, Joseph E. . W.W. Norton & Company. 2012: 560. ISBN 978-0393345063.  含有內容需登入查看的頁面 (link)
↑  Under The Influence: 60 Minutes' Steve Kroft Reports On Drug Lobbyists' Role in Passing Bill That Keeps Drug Prices High （页面存档备份，存于）. Lists Senators and Congress members who went on to high-paying jobs as pharmaceutical industry lobbyists after voting for Medicare Part D.
↑  The K Street Prescription （页面存档备份，存于）, By Paul Krugman, New York Times, January 20, 2006.
↑  Singer, Michelle. . CBS News 60 Minutes. March 29, 2007. （原始内容存档于2021-04-27）.
↑  {{cite web
 | url =https://www.manhattan-institute.org/html/older-drugs-shorter-lives-examination-health-effects-veterans-health-administration-formulary （页面存档备份，存于）
 | title = Older Drugs, Shorter Lives? An Examination of the Health Effects of the Veterans Health Administration Formulary
 | publisher = Dr. Frank R. Lichtenberg
 | date = 1 October 2005
 | accessdate = 16 March 2021
↑  Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D （页面存档备份，存于）. Health Affairs.  2009 Mar-Apr;28(2):w317-25.
↑  .   [2020-10-09]. （原始内容存档于2020-10-09）.
1 2  .   [2020-10-09]. （原始内容存档于2020-10-08）.